Learn how key European changes and trends like value-based pricing & the cancer drugs fund, the German healthcare reform and risk-sharing in Italy, affect Oncology market access to your drugs Europe. Engage stakeholders from all over Europe to discover what drives patient access and how to overcome barriers to reimbursement.

Drive your oncology business unit to commercial success:

- Understand the price negotiations after the German Healthcare Reform, and IQWIGs new end point guidelines

- How risk-sharing agreements differ across Europe for more targeted reimbursement strategies

- How to build innovation into your clinical trial design for a more stakeholder-centric value proposition
-